Offshoring pharma manufacturing increases risk, says study

September 12, 2011
Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news

Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …

Pharma manufacturing news in brief

September 12, 2011
Manufacturing and Production pharma manufacturing news

DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …

research_partnership_richard_head

Richard Head joins the Research Partnership

September 12, 2011
Sales and Marketing appointment, sales and marketing

Market research company the Research Partnership has appointed Richard Head as a director. He will be based at the company’s …

FDA recommends Xarelto for new approval

September 12, 2011
Sales and Marketing Xarelto, atrial fibrillation, stroke

FDA advisors have recommended Bayer and Johnson & Johnson’s Xarelto be approved in the US for the prevention of stroke …

GSK scales back breast cancer trial

September 12, 2011
Research and Development, Sales and Marketing GSK, Tyverb

GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …

Takeda moves potential first-in-class diabetes drug into phase III

September 12, 2011
Research and Development, Sales and Marketing TAK-875, Takeda, diabetes

Takeda has moved its potential first-in-class diabetes candidate TAK-875 into phase III clinical trials. The company hopes TAK-875 will offer …

Blog footer

Digital Pharma: Twitter slip-up shouldn’t silence pharma

September 9, 2011
Medical Communications, Sales and Marketing Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter

Bayer UK was recently ruled to have breached the ABPI Code of Practice by promoting prescription-only medicines to the general …

Pan appoints trio of new starters

September 9, 2011
Medical Communications appointment, medical communications

Pan Advertising has appointed a trio of new starters across its creative and client services teams. Maneesh Sharma joins the …

1hq_burton_paul

Branding agency 1HQ appoints Burton Paul

September 9, 2011
Medical Communications appointment, medical communications

Burton Paul has joined Windsor, UK-based branding agency 1HQ as client director to head up their health division. He has …

EMA grants first paediatric use marketing authorisation

September 9, 2011
Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures

The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …

Zytiga

European approval for prostate cancer drug Zytiga

September 8, 2011
Sales and Marketing Janssen, Jevtana, Johnson & Johnson, Zytiga, prostate cancer

Johnson & Johnson’s Zytiga has been approved in the EU for late-stage prostate cancer. Zytiga (abiraterone acetate) is now licenced …

Novartis

Everolimus approved to treat rare tumour disease

September 8, 2011
Sales and Marketing Novartis, SEGA, Votubia, everolimus

Novartis has gained EU approval for everolimus to be used to treat a rare non-cancerous tumour. Everolimus is already marketed …

New ABPI chief executive to focus on industry reputation

September 8, 2011
Research and Development, Sales and Marketing ABPI, industry relations

The new chief executive of the ABPI used his first public speech to focus on the reputation of the pharma …

Sanofi banks on personalised medicine for growth

September 8, 2011
Sales and Marketing Genzyme, Sanofi

Sanofi has nailed its colours to the mast of personalised medicine, banking on the purchase of US biotech company Genzyme, …

Algeta appoints first head of comms and investor relations

September 8, 2011
Medical Communications, Research and Development appointment, medical communications, research and development

Norwegian biotech Algeta has appointed Dr Mike Booth to the newly-created role of senior VP of communications and corporate affairs. …

Dendreon drops GSK as Provenge manufacturing partner

September 8, 2011
Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news

Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …

Enbrel

Forecasting future launch success

September 8, 2011
Sales and Marketing Champix, Enbrel, forecast planning, forecasting

Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …

Clinical research news in brief

September 8, 2011
Research and Development research and development news

This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …

Eisai shares risk with novel trial funding approach

September 7, 2011
Research and Development Eisai, clinical trials, research and development news

Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …

Battle over health reform begins again

September 7, 2011
Health and Social Care Bill, NHS, NHS reforms

The battle over the future of the NHS has began again as the Health and Social Care Bill yesterday returned …

The Gateway to Local Adoption Series

Latest content